Sentences with phrase «monoamine oxidase»

Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity

Association study of a monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response

The present study examined gene — environment correlations and Gene × Environment interactions for polymorphisms of three target genes, the serotonin transporter gene, the D4 dopamine receptor gene, and the monoamine oxidase A gene in relation to symptoms of anxiety, depression, and oppositional behavior.

Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment

In boys, low - activity monoamine oxidase A gene was associated with increases in child anxiety and depression in interaction with caretaker depression, hostility, family conflict, and family stress.

Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders

Platelet monoamine oxidase activity in endogenous depression

Childhood maltreatment, subsequent antisocial behaivor, and the role of monoamine oxidase A genotype

Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms: Depressive symtomatology among adolescents from low socioeconomic status backgrounds

A regulatory polymorphism of the monoamine oxidase - A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity

Fowler et al. (2009) found that a variable number tandem repeat (VNTR) polymorphism in the gene encoding monoamine oxidase A (responsible for catabolism of serotonin and other catecholamine neurotransmitters), and an insertion / deletion polymorphism in the SLC6A4 promoter (5 - HTTLPR) were associated with what the authors term the «emotional dysfunction» aspect of psychopathy (a construct that corresponds with CU traits) in a sample of adolescents with attention deficit hyperactivity disorder (ADHD)[18].

Monoamine oxidase A (MAOA) is a key enzyme in the catabolism of monoamines, especially serotonin.

Mesh terms: Aggression Analysis of Variance Animals Behavior, Animal Genetic Variation Macaca mulatta Male Maternal Deprivation Monoamine Oxidase Polymorphism, Genetic Promoter Regions, Genetic Random Allocation Social Environment

Previous research has reported that a functional polymorphism in the monoamine oxidase A (MAOA) gene promoter can moderate the association between early life adversity and increased risk for violence and antisocial behavior.

BACKGROUND: Allelic variation of the monoamine oxidase A (MAOA) gene has been implicated in conduct disorder and antisocial, aggressive behavior in humans when associated with early adverse experiences.

The clearest genetic link to aggressive behavior exists for the monoamine oxidase A (MAOA) gene which plays a key role in the catabolism of monoamines, including dopamine (DA), norepinephrine (NE), and serotonin (5 - HT)[7].

In their study they found a point mutation in the structural gene for monoamine oxidase A (MAOA), a neurochemical in the brain, which they associated with aggressive criminal behavior among a number of males in that family (Alper, 1995).

Differential functional variability of serotonin transporter and monoamine oxidase a genes in macaque species displaying contrasting levels of aggression - related behavior

A gene of potential interest is monoamine oxidase A (MAOA).

To determine whether participants with and without a PersD received different treatment, we assessed the percentage of participants receiving1 or more of the following: any psychotropic medication, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, benzodiazepines, atypical antidepressants, any psychosocial treatment, relaxation training, 1 or more cognitive techniques, 1 or more behavioral techniques, or psychodynamic therapy.

One such candidate is monoamine oxidase A (MAOA), an enzyme that breaks down neurochemicals such as serotonin and dopamine (Shih et al., 1999), and that is present in high concentrations within the anterior cingulate (Ginovart et al., 2006), a brain region closely associated with the distress of social rejection (Eisenberger et al., 2003).

Positron emission tomography quantification of [11C]- harmine binding to monoamine oxidase - A in the human brain

The serotonin transporter and monoamine oxidase are targets of the two most commonly prescribed classes of antidepressants, selective serotonin reuptake inhibitors (e.g. Prozac) and monoamine oxidase inhibitors (e.g. Nardil), respectively.

These may include accumulation of B - amyloid, declining neurotransmitter activities, or increased activity of monoamine oxidase - B, an enzyme that may catalyze the metabolism of dopamine.1

Monoamine oxidase B, or MAOB, has been found to increase in older dogs.

Do not give within 14 days before or after treatment with a monoamine oxidase inhibitor.

Seek the advice of a veterinarian if using with with other CNS depressant drugs such as acepromazine; monoamine oxidase inhibitors (MAOIs) such as selegilene and Preventic collars; anticholinergics such as atropine and metoclopramide; and medications used for wheezing such as theophylline, epinephrine or ephedrine.

This medication prolongs the activity of dopamine in the brain by inhibiting the enzymatic function of monoamine oxidase (MAO).

NOTE: Amitraz is a drug of the monoamine oxidase inhibitor class.

Clomicalm Tablets should not be given in combination, or within 14 days before or after treatment with a monoamine oxidase inhibitor [e.g. selegiline hydrochloride (Ldeprenyl), amitraz].

Yes, but possible interactions may occur with cimetidine, chloramphenicol, furazolidone, monoamine oxidase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs such as aspirin, meloxicam), phenothiazines (ex.

A monoamine oxidase inhibitor (MAOI) Also known as L - Deprenyl Given by mouth Reasons for prescribing:

These drugs may interact with insulin: anabolic steroids, alcohol, aspirin and other salicylates, beta - adrenergic blockers, cardiac glycosides, dextrothyroxine, dobutamine, epinephrine, estrogen / progesterone combinations, furosoemide, glucocorticoids, guanethidine, monoamine oxidase inhibitors, phenylbutazone, sulfinpyrazone, tetracycline, thyiazide diuretics and thyroid medications.

Selegiline, a monoamine oxidase inhibitor (MAOI) provides help...

These are benzodiazepines (BZs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).

Inhibitors of Monoamine Oxidase - A are drugs that can not be used with miratazpine but MAO - A inhibitors are not used in veterinary medicine so this is of little concern.

An antiparasitic dip A monoamine oxidase inhibitor (MAOI) Amitraz dip is applied topically Reasons for prescribing:

Incompatible with monoamine oxidase inhibitors.

Drugs considered Monoamine Oxidase Inhibitors can promote the potential for dry mouth & difficulty urinating.

Mitaban Dip is a monoamine oxidase inhibitor (MAOI).

The Preventic Tick Collar contains Amitraz, a monoamine oxidase inhibitor (MAOI), and should not be used on pets being given any other MAOI such as Anipryl or selegiline.

Do not use a monoamine oxidase inhibitor (MAOI) such as Anipryl, Selegiline, or a Preventic Flea Collar on your pet while giving this medication.

Preventic Collar contains a monoamine oxidase inhibitor (MAOI) and should not be used on pets being given any other MAOI.

Inhibitors of monoamine oxidase - A (MAO - A) can not be used with miratazpine, as this combination increases the risk of the aforementioned serotonin.

For example, a recent study demonstrates differences in the epigenetic state (as evidenced by DNA methylation) of the Monoamine Oxidase A gene across Beagles, German Shepherds, and Sapsaree Dogs.

Is a selective monoamine oxidase - B inhibitor, which could enhance catecholamine neuronactivity and increases dopamine levels in dogs.

The most common class of drugs used in behavior modification are: benzodiazepines (BZs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs), according to the ASPCA.These medications may be prescribed by a veterinarian or board certified veterinary behaviorist.

Do not use in conjunction with monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, tricyclic antidepressants, or pressor agents.

Monoamine oxidase inhibitors (MAOIs) are commonly used to treat cognitive dysfunction.

According to the website, amitraz (a chemical that is an alpha2 - adrenergic agonist and monoamine oxidase inhibitor) can cause lethargy, dilated pupils, drooling, vomiting, and even low or high heart rates, to name just a few, if this chemical is ingested or the collar is applied incorrectly.